Surface display of the cholera toxin B subunit on Staphylococcus xylosus and Staphylococcus carnosus.
The heterologous surface expression of the cholera toxin B subunit (CTB) from Vibro cholerae in two staphylococcal species, Staphylococcus xylosus and Staphylococcus carnosus, has been investigated. The gene encoding native CTB (103 amino acids) was introduced into gene constructs encoding chimeric receptors designed to be translocated and anchored on the outer cell surface of the staphylococci. Since functionality of CTB is correlated with its ability to form pentamers and the capacity of the pentameric CTB to bind the GM1 ganglioside, both the surface accessibility and the functionality of the surface-displayed CTB receptors were evaluated. It could be concluded that the chimeric receptors were targeted to the cell wall of the staphylococci, since they could be released by lysostaphin treatment and, after subsequent affinity purification, identified as full-length products by immunoblotting. Surface accessibility of the chimeric receptors was demonstrated by a colorimetric assay and by immunofluorescence staining with a CTB-reactive rabbit antiserum. Pentamerization was investigated by using a monoclonal antibody described to be specific for pentameric CTB, and the functionality of the receptors was tested in a binding assay with digoxigenin-labelled GM1. It was concluded that functional CTB was present on both types of staphylococci, and for S. carnosus, the reactivity to the pentamer-specific monoclonal antibody and in the GM1 binding assay was indeed significant. The implications of the results for the design of live bacterial vaccine delivery systems intended for administration by the mucosal route are discussed.
Liljeqvist
S
S
Department of Biochemistry and Biotechnology, Royal Institute of Technology, Stockholm, Sweden.
Samuelson
P
P
Hansson
M
M
Nguyen
T N
TN
Binz
H
H
Ståhl
S
S
D000907:Antibodies, Bacterial; D002473:Cell Wall / Q000378:metabolism; D002772:Cholera Toxin / Q000235:genetics* / Q000276:immunology / Q000378:metabolism*; D004076:Digoxigenin / Q000378:metabolism; D019084:Fluorescent Antibody Technique, Indirect; D005677:G(M1) Ganglioside / Q000276:immunology / Q000378:metabolism; D015870:Gene Expression; D008248:Lysostaphin / Q000494:pharmacology; D008565:Membrane Proteins / Q000235:genetics / Q000276:immunology / Q000378:metabolism; D008969:Molecular Sequence Data; D010957:Plasmids; D011956:Receptors, Cell Surface / Q000235:genetics / Q000276:immunology / Q000378:metabolism; D011994:Recombinant Proteins / Q000096:biosynthesis / Q000235:genetics / Q000302:isolation & purification; D013210:Staphylococcus / Q000235:genetics* / Q000378:metabolism*; D014734:Vibrio cholerae / Q000235:genetics*
D000907:Antibodies, Bacterial; D008565:Membrane Proteins; D011956:Receptors, Cell Surface; D011994:Recombinant Proteins; D005677:G(M1) Ganglioside; D002772:Cholera Toxin; D008248:Lysostaphin; D004076:Digoxigenin